Minnesota experts raise their concerns about FDA approval process

05/19/2010 | Star Tribune (Minneapolis-St. Paul, Minn.)

Several speakers expressed concerns with the FDA's approval system for medical devices, such as long timelines and a lack of certainty in the process, during a town hall meeting in Minneapolis-St. Paul, Minn., on Tuesday. Meanwhile, Dr. Jeffrey Shuren, director of the FDA's device unit, assured the participants that the agency has no plans to terminate the 510(k) program, and said the agency plans to disclose possible changes to the program in a few weeks.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC